Clinical Trial Update: MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled trial evaluating the safety and efficacy of SSR240600C in adults with overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• SSR240600C

Snippet

Sponsor: Sanofi | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED